Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 6.312% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CCN(CC)S(=O)(=O)c1cccc(NC(=O)CNc2cccc(S(=O)(=O)N3CCOCC3)c2)c1
b OC(c1ccccn1)c1c[nH]c2ccccc12
c CC(C)[C@]1(c2ccc(Cl)cc2)ON(c2ccccc2C(F)(F)F)C1=O
Answer: c. CC(C)[C@]1(c2ccc(Cl)cc2)ON(c2ccccc2C(F)(F)F)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)[C@]1(c2ccc(Cl)cc2)ON(c2ccccc2C(F)(F)F)C1=O
CC(C)[C@]1(c2ccc(Cl)cc2)ON(c2ccccc2C(F)(F)F)C1=O
(4R)-4-(4-chlorophenyl)-4-propan-2-yl-2-[2-(trifluoromethyl)phenyl]oxazetidin-3-one